Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Public perceptions of presymptomatic testing for Alzheimer disease.

Mayo Clinic proceedings - 1 Oct 2014

Caselli Richard J, Langbaum Jessica, Marchant Gary E, Lindor Rachel A, Hunt Katherine S, Henslin Bruce R, Dueck Amylou C, Robert Jason S

Abstract excerpt

OBJECTIVE: To explore the self-expressed desire for, envisioned reaction to, and basic understanding of presymptomatic Alzheimer disease (AD)-related genetic and biomarker tests. PATIENTS AND METHODS: The Alzheimer's Prevention Registry is an online community of people at least 18 years of age who are interested in AD prevention research for purely informational purposes or to be considered for possible research...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Arizona

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Attitude to Health

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Population Surveillance

Share to Prevalence

Source

Open in PubMed Open full text

Identifiers

PMID: 25171823
DOI: 10.1016/j.mayocp.2014.05.016
PMCID: PMC4369785

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Public perceptions of presymptomatic testing for Alzheimer disease.PMID 25171823Read ↗

To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk.Semantic proximity Read ↗

The effect of disease risk probability and disease type on interest in clinic-based versus direct-to-consumer genetic testing services.Semantic proximity Read ↗

Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.Semantic proximity Read ↗

Genetic testing for neurodegenerative diseases: Ethical and health communication challenges.Semantic proximity Read ↗

Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk.Semantic proximity Read ↗

Considerations regarding a diagnosis of Alzheimer’s Disease before dementia: a systematic reviewSemantic proximity Read ↗

Young people's moral attitudes and motivations towards direct-to-consumer genetic testing for inherited risk of Alzheimer disease.Semantic proximity Read ↗

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: A survey studySemantic proximity Read ↗

"It seems enormously valuable to me." Perspectives of Dutch (potential) carriers of genetic FTD on onset-predictive biomarker testing.Semantic proximity Read ↗

"Well, good luck with that": reactions to learning of increased genetic risk for Alzheimer disease.Semantic proximity Read ↗

Consumer preferences for the predictive genetic test for Alzheimer disease.Semantic proximity Read ↗

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.